Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00426530
Status:
COMPLETED
Last Update Posted:
2020-12-21
First Post:
2007-01-23
Brief Title:
Safety of Everolimus in Combination Therapy in Patients With HER2-overexpressing Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasm Metastasis |
| Breast Neoplasms |